Improving retinal vascular endothelial cell tropism through rational rAAV capsid design
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285370 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Ramesh Periasamy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America. Hauptthemen laut MEDLINE: Capsid, Dependovirus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Vascular endothelial cells (VEC) are essential for retinal homeostasis and their dysfunction underlies pathogenesis in diabetic retinopathy (DR) and exudative age-related macular degeneration (AMD). Studies have shown that recombinant adeno-associated virus (rAAV) vectors are effective at delivering new genetic material to neural and glial cells within the retina, but targeting VECs remains challenging. To overcome this limitation, herein we developed rAAV capsid mutant vectors with improved tropism towards retinal VEC. rAAV2/2, 2/2[QuadYF-TV], and rAAV2/9 serotype vectors (n = 9, capsid mutants per serotype) expressing GFP were generated by inserting heptameric peptides (7AA) designed to increase endothelial targeting at positions 588 (2/2 and 2/2[QuadYF-TV] or 589 (2/9) of the virus protein (VP 1–3). The packaging and transduction efficiency of the vectors were assessed in HEK293T and bovine VECs using Fluorescence microscopy and flow cytometry, leading to the identification of one mutant, termed EC5, that showed improved endothelial tropism when inserted into all three capsid serotypes. Intra-ocular and intravenous administration of EC5 mutants in C57Bl/6j mice demonstrated moderately improved transduction of the retinal vasculature, particularly surrounding the optic nerve head, and evidence of sinusoidal endothelial cell transduction in the liver. Most notably, intravenous administration of the rAAV2/2[QuadYF-TV] EC5 mutant led to a dramatic and unexpected increase in cardiac muscle transduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Science, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
- Cell Biology, Neurobiology, Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
- Department of Pediatrics, Powell Gene Therapy Center, University of Florida, Gainesville, FL, United States of America.
- Department of Pediatrics, Division of Cellular and Molecular Biology, University of Florida, Gainesville, FL, United States of America.
ORCID-Profile: Daniel M Lipinski
Förderung
- NEI NIH HHS
- NIH HHS
- National Eye Institute
Zitieren
APA
Periasamy, R., Patel, D. D., Boye, S. L., Boye, S. E., & Lipinski, D. M. (2023). Improving retinal vascular endothelial cell tropism through rational rAAV capsid design. PLOS ONE. https://doi.org/10.1371/journal.pone.0285370
Vancouver
Periasamy R, Patel DD, Boye SL, Boye SE, Lipinski DM. Improving retinal vascular endothelial cell tropism through rational rAAV capsid design. PLOS ONE. 2023. doi:10.1371/journal.pone.0285370
BibTeX
@article{Periasamy2023,
author = {Periasamy, Ramesh and Patel, Dwani D and Boye, Sanford L and Boye, Shannon E and Lipinski, Daniel M},
title = {Improving retinal vascular endothelial cell tropism through rational rAAV capsid design},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285370}
}
EUVIMED